TY -的AU -赖特,海莉AU -马丁,信仰盟——Clyne温迪AU -克拉克,凯恩C T非盟- Matouskova,加芙盟——McGillion迈克尔AU -特纳,安德鲁PY - 2021 DA - 2021/11/5 TI -数码自我管理项目(帮助有效地克服困难)癌症患者:随机对照试验可行性乔- J地中海互联网Res SP - e28322六世- 23 - 11千瓦——自我管理KW -癌症千瓦生存KW -数字KW -积极心理学AB -背景:我们提出了一个1:1分配比例的可行性、随机等待列表对照组(CG)并行设计研究的结果。参与者被随机分为干预组(IG)或候补组(CG)。这项干预是一项为期6周的数字自我管理计划，名为“帮助有效克服问题”(HOPE)，针对癌症患者。目的:本研究旨在测试癌症患者数字化自我管理计划的可行性。这将为最终随机对照试验的设计提供依据。此外，通过次要结果对HOPE项目影响的初步评估将用于评估试验背景下的疗效信号。方法:参与者从麦克米伦癌症支持中心推荐的机会样本中抽取，并通过电子邮件邀请他们参与研究(N=61)。主要结果包括招募率、保留率、随访率、完成率和依从率、样本量和效应量估计，以及最终试验的进展标准评估。次要结果是自我报告测量参与者的积极心理健康、抑郁、焦虑和患者激活(即对管理癌症的信心)。 The intervention and data collection took place on the web. Results: The recruitment rate was 77% (47/61). A total of 41 participants completed the baseline questionnaires and were randomized to either the IG (n=21) or the waitlist CG (n=20). The retention rate (attending all program sessions) was greater than 50% (all: 21/41, 51%, IG: 10/21, 48%; and CG: 11/20, 55%). The follow-up rate (completing all questionnaires) was greater than 80% (all: 33/41, 80%; IG: 16/21, 76%; and CG: 17/20, 85%). The completion rate (attending ≥3 sessions and completing all questionnaires) was greater than 60% (all: 25/41, 61%; IG: 13/21, 62%; and CG: 12/20, 60%). Engagement data showed that participants viewed between half (5.1/10, 51%) and three-quarters (12.2/16, 76%) of the pages in each session. Conclusions: All progression criteria for a definitive trial were met, as supported by the primary outcome data. The IG showed improved postprogram scores on measures of positive mental well-being, depression, anxiety, and patient activation. A full-scale trial of the digital HOPE program for people with cancer will allow us to fully evaluate the efficacy of the intervention relative to a CG. Trial Registration: ISRCTN Registry ISRCTN79623250; http://www.isrctn.com/ISRCTN79623250 International Registered Report Identifier (IRRID): RR2-10.2196/24264 SN - 1438-8871 UR - //www.mybigtv.com/2021/11/e28322 UR - https://doi.org/10.2196/28322 UR - http://www.ncbi.nlm.nih.gov/pubmed/34738912 DO - 10.2196/28322 ID - info:doi/10.2196/28322 ER -